- Home
- MRK vs TMUS Comparison
MRK vs TMUS Comparison
Compare MRK & TMUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRK
- TMUS
- Stock Information
- Founded
- MRK 2000
- TMUS 1994
- Country
- MRK United States
- TMUS United States
- Employees
- MRK N/A
- TMUS N/A
- Industry
- MRK Biotechnology: Pharmaceutical Preparations
- TMUS Telecommunications Equipment
- Sector
- MRK Health Care
- TMUS Telecommunications
- Exchange
- MRK Nasdaq
- TMUS Nasdaq
- Market Cap
- MRK 218.2B
- TMUS 248.6B
- IPO Year
- MRK N/A
- TMUS N/A
- Fundamental
- Price
- MRK $78.00
- TMUS $262.04
- Analyst Decision
- MRK Buy
- TMUS Buy
- Analyst Count
- MRK 15
- TMUS 20
- Target Price
- MRK $119.86
- TMUS $251.95
- AVG Volume (30 Days)
- MRK 19.8M
- TMUS 4.8M
- Earning Date
- MRK 04-24-2025
- TMUS 04-24-2025
- Dividend Yield
- MRK 4.16%
- TMUS 1.34%
- EPS Growth
- MRK 4714.29
- TMUS 39.39
- EPS
- MRK 6.74
- TMUS 9.66
- Revenue
- MRK $64,168,000,000.00
- TMUS $81,400,000,000.00
- Revenue This Year
- MRK $2.41
- TMUS $7.22
- Revenue Next Year
- MRK $6.31
- TMUS $5.12
- P/E Ratio
- MRK $11.57
- TMUS $27.13
- Revenue Growth
- MRK 6.74
- TMUS 3.62
- 52 Week Low
- MRK $75.93
- TMUS $159.41
- 52 Week High
- MRK $134.63
- TMUS $276.49
- Technical
- Relative Strength Index (RSI)
- MRK 33.43
- TMUS 52.77
- Support Level
- MRK $75.93
- TMUS $258.96
- Resistance Level
- MRK $80.02
- TMUS $267.96
- Average True Range (ATR)
- MRK 3.36
- TMUS 9.00
- MACD
- MRK -0.58
- TMUS 0.30
- Stochastic Oscillator
- MRK 14.44
- TMUS 68.90
About MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.
About TMUS T-Mobile US Inc.
Deutsche Telekom merged its T-Mobile USA unit with prepaid specialist MetroPCS in 2013, and that firm merged with Sprint in 2020, creating the second-largest wireless carrier in the us. T-Mobile now serves 77 million postpaid and 21 million prepaid phone customers, equal to around 30% of the us retail wireless market. The firm entered the fixed-wireless broadband market aggressively in 2021 and now serves more than 5 million residential and business customers. In addition, T-Mobile provides wholesale services to resellers.